Calyxt Inc CLXT

NAS: CLXT | ISIN: US13173L1070   2/08/2023
19,51 USD (-3,70%)
(-3,70%)   2/08/2023

19 mei 2023 · Calyxt Announces Stockholder Approval of Merger With Cibus · Persbericht

1 mei 2023 · Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update · Persbericht

24 april 2023 · Calyxt Completes One-for-Ten Reverse Stock Split · Persbericht

18 april 2023 · Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC · Persbericht

7 april 2023 · Calyxt Announces Effective Date of Reverse Stock Split · Persbericht

2 maart 2023 · Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update · Persbericht

15 februari 2023 · Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC · Persbericht

17 januari 2023 · Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company · Persbericht

18 november 2022 · Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil · Persbericht

17 november 2022 · Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule · Persbericht

3 november 2022 · Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update · Persbericht

1 november 2022 · Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing · Persbericht

27 oktober 2022 · Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time · Persbericht

25 oktober 2022 · Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants · Persbericht

6 oktober 2022 · Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients · Persbericht

22 september 2022 · Calyxt, Inc. Exploring Strategic Alternatives · Persbericht

7 september 2022 · Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference · Persbericht

4 augustus 2022 · Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update · Persbericht

28 juli 2022 · Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference · Persbericht

21 juli 2022 · Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time · Persbericht

Mijn selecties